Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutations.

Autor:	Yasutake, Yoshiaki1,2 (AUTHOR) y-yasutake@aist.go.jp, Hattori, Shin-ichiro3 (AUTHOR), Kumamoto, Hiroki4 (AUTHOR), Tamura, Noriko1 (AUTHOR), Maeda, Kenji3,5 (AUTHOR), Mitsuya, Hiroaki3,6,7 (AUTHOR) hmitsuya@hosp.ncgm.go.jp
Zdroj:	Scientific Reports. 7/8/2024, Vol. 14 Issue 1, p1-13. 13p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu